Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials

🇺🇸 Bloomberg (US) —

AI Summary

Bambusa Therapeutics has filed for an initial public offering to raise funds for clinical trials of treatments for eczema and other inflammatory disorders. The filing links the company's financing plans to development of its drug pipeline.

Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.

Markets Deals Health Bambusa Therapeutics IPO eczema clinical trials inflammation biotechnology

Read original source →